产品和服务 / 产品类型 / 重组蛋白 / 药物靶点

Recombinant Human CD44 Protein (RP00535)

Human CD44 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.

The purity of Human CD44 is greater than 95% as determined by SEC-HPLC.

Immobilized Human CD44, His Tag at 0.5 μg/mL (100 μL/well) on the plate. Dose response curve for Anti-CD44 Antibody, hFc Tag with the EC50 of 5.5ng/mL determined by ELISA.

All(3)|
货号: RP00535
促销价:   ¥3200
货    期:在线咨询货期
抗体定制服务咨询 |
扫码下单
享受积分

详细信息

种属
Human
表达宿主
HEK293 cells
Calculated MW
27.91 kDa
Observed MW
45-68 kDa
标签
C-His
纯度
> 95% by SDS-PAGE;> 95% by HPLC
内毒素
< 1 EU/μg of the protein by LAL method
制剂
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
描述
Recombinant Human CD44 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln21-Pro220 & Gln386-Ala427) of Human CD44 (Accession #P16070-1) fused with a C-His tag at the C-terminus.
储存
Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt.
After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week.未开盖的干粉蛋白在 -20°C至-80°C可保存12个月;
复溶之后,蛋白溶液在-20°C及以下可保存3个月,在2-8℃可保存1周。
复溶
Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles.收到重组蛋白产品之后请检查蛋白冻干粉末是否贴于瓶底,如果粉末浮起,开盖之前请先低温离心。将蛋白用说明书中指定的缓冲液复溶至0.1-0.5 mg/mL(请注意蛋白复溶浓度不能低于0.1 mg/mL),室温平衡5-10 min保证充分溶解,复溶过程中请不要剧烈涡旋及吹打蛋白溶液。如需长期储存,建议复溶时添加载体蛋白或者稳定剂(如0.1% BSA, 5% HSA, 10% FBS 或者 5% 海藻糖),同时将复溶后的蛋白溶液按照需求进行分装,储存于-20°C至-80°C,随取随用,避免反复冻融。

蛋白复溶计算器

请在蛋白复溶计算器中输入蛋白总质量和所需终浓度,快速计算您需要添加溶液的体积吧!
=
÷

客户数据及评论 (0)

折叠内容

背景信息

CD44 is a hyaluronan binding cell surface signal transducing receptor that influences motility, cell survival and proliferation as well as the formation of tumor microenvironment. CD44 contains two variable regions encoded by variable exons. Alternative splicing, which is often deregulated in cancer, can produce various isoforms of CD44 with properties that may have different tissue specific effects and therefore even diverse effects on cancer progression

>